Cg Oncology Inc’s filing revealed that its Director POST LEONARD E unloaded Company’s shares for reported $28610.0 on Feb 18 ’25. In the deal valued at $28.61 per share,1,000 shares were sold. As a result of this transaction, POST LEONARD E now holds 0 shares worth roughly $0.0.
Then, POST LEONARD E sold 1,000 shares, generating $29,660 in total proceeds. Upon selling the shares at $29.66, the Director now owns 0 shares.
Before that, Song Hong Fang sold 700,000 shares. Cg Oncology Inc shares valued at $19,600,000 were divested by the Director at a price of $28.00 per share. As a result of the transaction, Song Hong Fang now holds 3,003,931 shares, worth roughly $75.4 million.
TD Cowen initiated its Cg Oncology Inc [CGON] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. RBC Capital Mkts began covering CGON with “an Outperform” recommendation on September 23, 2024. ROTH MKM started covering the stock on August 28, 2024. It rated CGON as “a Buy”.
Price Performance Review of CGON
On Monday, Cg Oncology Inc [NASDAQ:CGON] saw its stock fall -2.94% to $25.10. Over the last five days, the stock has lost -6.27%. Cg Oncology Inc shares have fallen nearly -12.48% since the year began. Nevertheless, the stocks have fallen -43.47% over the past one year. While a 52-week high of $47.78 was reached on 01/07/25, a 52-week low of $24.16 was recorded on 02/28/25. SMA at 50 days reached $28.77, while 200 days put it at $33.12.
Levels Of Support And Resistance For CGON Stock
The 24-hour chart illustrates a support level at 24.46, which if violated will result in even more drops to 23.82. On the upside, there is a resistance level at 26.00. A further resistance level may holdings at 26.89. The Relative Strength Index (RSI) on the 14-day chart is 34.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.65, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.05%. Stochastics %K at 19.29% indicates the stock is a buying.
The most recent change occurred on June 28, 2024 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $65 price target.
